Finance

Lists
CBHD:ETR
Coloplast A/S
56,44 €
+0,82%
(+0,46) 1D
30 სექ, 09:37:24 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CBHD...
Open
56,16 €
High
56,44 €
Low
56,16 €
Mkt. cap
88,45 მლრდ.
Avg. vol.
1,68 ათ.
Volume
10,00
52-wk high
84,34 €
52-wk low
49,48 €
No. of employees
17 ათ.
Open
56,16 €
High
56,44 €
Low
56,16 €
Mkt. cap
88,45 მლრდ.
Avg. vol.
1,68 ათ.
Volume
10,00
52-wk high
84,34 €
52-wk low
49,48 €
No. of employees
17 ათ.
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
17 საათის წინ
Coloplast stock after-hours at EUR 55.84: minus 1.13 percent
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast A/S
CEO-
Employees17,2 ათ.
Founded1957
HeadquartersHumlebaek, დედაქალაქის რეგიონი, დანია
SectorMedical device
Last report
18 აგვ. 2026
Fiscal period
Q3 2026
EPS / Est. (DKK)
- / 6,06 DKK
Revenue / Est. (DKK)
7,36 მლრდ. / 7,27 მლრდ.
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
6,96 მლრდ.
7,04 მლრდ.
7,08 მლრდ.
7,36 მლრდ.
Cost of goods sold
2,20 მლრდ.
2,31 მლრდ.
2,37 მლრდ.
2,45 მლრდ.
Cost of revenue
2,20 მლრდ.
2,31 მლრდ.
2,37 მლრდ.
2,45 მლრდ.
Research and development expenses
249,00 მლნ.
247,00 მლნ.
254,00 მლნ.
281,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,62 მლრდ.
2,64 მლრდ.
2,67 მლრდ.
2,72 მლრდ.
Operating expense
2,79 მლრდ.
2,88 მლრდ.
2,90 მლრდ.
2,98 მლრდ.
Total operating expenses
4,99 მლრდ.
5,19 მლრდ.
5,26 მლრდ.
5,43 მლრდ.
Operating income
1,97 მლრდ.
1,85 მლრდ.
1,82 მლრდ.
1,93 მლრდ.
Other non operating income
-6,00 მლნ.
42,00 მლნ.
-188,00 მლნ.
-
EBT including unusual items
1,56 მლრდ.
1,79 მლრდ.
-1,24 მლრდ.
1,87 მლრდ.
EBT excluding unusual items
1,81 მლრდ.
1,83 მლრდ.
1,78 მლრდ.
1,89 მლრდ.
Income tax expense
680,00 მლნ.
394,00 მლნ.
-273,00 მლნ.
412,00 მლნ.
Effective tax rate
43,73%
22,00%
21,95%
21,98%
Other operating expenses
-80,00 მლნ.
-6,00 მლნ.
-23,00 მლნ.
-25,00 მლნ.
Net income
875,00 მლნ.
1,40 მლრდ.
-971,00 მლნ.
1,46 მლრდ.
Net profit margin
12,57%
19,84%
-13,71%
19,88%
Earnings per share
4,67
-
6,16
-
Interest and investment income
22,00 მლნ.
32,00 მლნ.
149,00 მლნ.
169,00 მლნ.
Interest expense
-152,00 მლნ.
-164,00 მლნ.
-
-206,00 მლნ.
Net interest expenses
-130,00 მლნ.
-132,00 მლნ.
149,00 მლნ.
-37,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,20 მლრდ.
2,20 მლრდ.
2,17 მლრდ.
2,29 მლრდ.
Gain or loss from assets sale
2,00 მლნ.
-
1,00 მლნ.
-5,00 მლნ.
AI content may include mistakes. Learn more
Google აპები